Daily as of 3 Nov 16:00 ET
- Price
- below both $86.92 vs 50 $96.14 / 200 $96.89
- Projection
- No cross projected
- Test
- Cross test window open, no test bar yet
- Last cross
- ๐Death cross 2 Nov 2026 ยท projected 15 bars out
BioNTech SE (BNTX) is a NASDAQ-listed ADR that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat below the 200 on the daily since Nov 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 2 Nov 2026 | ๐Death moderate | daily | 15 bars out | Active Cross Test |
| 22 Oct 2026 | ๐Death | 4-hour | 18 bars out | Not tested |
| 23 Sep 2026 | ๐จGolden flat | daily | 14 bars out | 7 bar cross test |
| 21 Aug 2026 | ๐จGolden | 4-hour | 4 bars out | Not tested |
| 27 Mar 2026 | ๐Death moderate | daily | 11 bars out | Not tested |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.